Skip to main content
Premium Trial:

Request an Annual Quote

Biological Dynamics, OHSU Partner to Validate Pancreatic Cancer Early Detection Test

NEW YORK – Biological Dynamics said on Wednesday that it has partnered with Oregon Health & Science University to study its ExoVita Pancreas assay for pancreatic cancer early detection.

Through the collaboration, researchers at OHSU's Brenden-Colson Center for Pancreatic Care will evaluate 520 samples from patients with early-stage pancreatic cancers, from those with benign pancreatic conditions such as cysts, and from healthy individuals.

The ExoVita Pancreas test is designed to isolate exosomes with pancreatic ductal adenocarcinoma-specific protein biomarkers from patients' blood samples. Last month, the firm announced that it had validated and launched the laboratory-developed test through its CLIA-certified and CAP-accredited laboratory as a tool to detect stage I and stage II pancreatic cancer.

San Diego-based Biological Dynamics is further validating the test among a population at high risk for pancreatic cancer through its ExoLuminate trial. In January, the firm announced a similar research collaboration with NYU Langone Perlmutter Cancer Center.

"The Brenden-Colson Center for Pancreatic Care are pioneers in integrating cutting-edge technologies into their research, and were early adopters of exosome isolation on the ExoVerita platform," Biological Dynamics CEO Paul Billings said in a statement. "This partnership is another step towards providing diagnostics for early cancer detection that are reliable and affordable for the surveillance of high-risk patients."

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.